ELANCO ANIMAL HEALTH INC (ELAN) Stock Price, Forecast & Analysis
USA - New York Stock Exchange - NYSE:ELAN - US28414H1032 - Common Stock
ELAN Key Statistics, Chart & Performance
The current stock price of ELAN is 21.3 USD. In the past month the price decreased by -6.82%. In the past year, price increased by 76.03%.
ELAN Latest News, Press Relases and Analysis
ELAN Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| LLY | ELI LILLY & CO | 45.19 | 939.37B | ||
| JNJ | JOHNSON & JOHNSON | 19.9 | 497.62B | ||
| MRK | MERCK & CO. INC. | 11.08 | 242.29B | ||
| PFE | PFIZER INC | 8.06 | 146.58B | ||
| BMY | BRISTOL-MYERS SQUIBB CO | 7.81 | 104.25B | ||
| ZTS | ZOETIS INC | 18.62 | 52.03B | ||
| RPRX | ROYALTY PHARMA PLC- CL A | 9.31 | 22.09B | ||
| VTRS | VIATRIS INC | 4.98 | 13.36B | ||
| CORT | CORCEPT THERAPEUTICS INC | 96.94 | 8.97B | ||
| AXSM | AXSOME THERAPEUTICS INC | N/A | 7.52B | ||
| BLTE | BELITE BIO INC - ADR | N/A | 5.13B | ||
| CRNX | CRINETICS PHARMACEUTICALS IN | N/A | 4.56B |
Related stock screener links
About ELAN
Company Profile
Elanco Animal Health, Inc. develops, manufactures, and markets products for pets and farm animals. The company is headquartered in Greenfield, Indiana and currently employs 9,000 full-time employees. The company went IPO on 2018-09-20. The firm's product portfolio is sold in more than 90 countries and serves animals across many species, primarily dogs and cats (collectively, pet health) and cattle, poultry, swine, and sheep (collectively, farm animal). The company has a diverse portfolio of products marketed under approximately 200 brands, including products for both pets and farm animals. The firm's global pet health portfolio is focused on parasiticides, vaccines and therapeutics. Its pet health products include Advantage Family, Atopica, Credelio Family, Drontal Family, Galliprant, Interceptor Plus, Milbemax, Onsior, Seresto, Trifexis, and TruCan. Its farm animal products include AviPro, Baytril, Catosal, Denagard, Experior, Hemicell, Maxiban/Monteban, Pulmotil, Rumensin, and Surmax. Its customers include consultants, veterinarians, farm animal producers and resellers.
Company Info
ELANCO ANIMAL HEALTH INC
2500 Innovation Way N
Greenfield INDIANA 46140 US
CEO: Jeffrey N. Simmons
Employees: 9225
Phone: 18773526261
ELANCO ANIMAL HEALTH INC / ELAN FAQ
What does ELANCO ANIMAL HEALTH INC do?
Elanco Animal Health, Inc. develops, manufactures, and markets products for pets and farm animals. The company is headquartered in Greenfield, Indiana and currently employs 9,000 full-time employees. The company went IPO on 2018-09-20. The firm's product portfolio is sold in more than 90 countries and serves animals across many species, primarily dogs and cats (collectively, pet health) and cattle, poultry, swine, and sheep (collectively, farm animal). The company has a diverse portfolio of products marketed under approximately 200 brands, including products for both pets and farm animals. The firm's global pet health portfolio is focused on parasiticides, vaccines and therapeutics. Its pet health products include Advantage Family, Atopica, Credelio Family, Drontal Family, Galliprant, Interceptor Plus, Milbemax, Onsior, Seresto, Trifexis, and TruCan. Its farm animal products include AviPro, Baytril, Catosal, Denagard, Experior, Hemicell, Maxiban/Monteban, Pulmotil, Rumensin, and Surmax. Its customers include consultants, veterinarians, farm animal producers and resellers.
What is the current price of ELAN stock?
The current stock price of ELAN is 21.3 USD. The price increased by 4.26% in the last trading session.
Does ELAN stock pay dividends?
ELAN does not pay a dividend.
What is the ChartMill rating of ELANCO ANIMAL HEALTH INC stock?
ELAN has a ChartMill Technical rating of 8 out of 10 and a ChartMill Fundamental rating of 4 out of 10.
What do analysts say about ELANCO ANIMAL HEALTH INC (ELAN) stock?
21 analysts have analysed ELAN and the average price target is 25.16 USD. This implies a price increase of 18.12% is expected in the next year compared to the current price of 21.3.
What is the employee count for ELAN stock?
ELANCO ANIMAL HEALTH INC (ELAN) currently has 9225 employees.
Can you provide the short interest for ELAN stock?
The outstanding short interest for ELANCO ANIMAL HEALTH INC (ELAN) is 4.57% of its float.
ELAN Technical Analysis
ChartMill assigns a technical rating of 8 / 10 to ELAN. When comparing the yearly performance of all stocks, ELAN is one of the better performing stocks in the market, outperforming 92.13% of all stocks.
ELAN Fundamental Analysis
ChartMill assigns a fundamental rating of 4 / 10 to ELAN. There are concerns on the financial health of ELAN while its profitability can be described as average.
ELAN Financial Highlights
Over the last trailing twelve months ELAN reported a non-GAAP Earnings per Share(EPS) of 0.96. The EPS increased by 12.94% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 0.78% | ||
| ROA | 0.27% | ||
| ROE | 0.53% | ||
| Debt/Equity | 0.59 |
ELAN Forecast & Estimates
21 analysts have analysed ELAN and the average price target is 25.16 USD. This implies a price increase of 18.12% is expected in the next year compared to the current price of 21.3.
For the next year, analysts expect an EPS growth of 4.8% and a revenue growth 5.43% for ELAN